Axogen, inc. begins processing avance® nerve graft at new state-of-the-art facility in dayton, ohio

Alachua, fla. and tampa, fla., aug. 21, 2023 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the successful first week of processing for avance nerve graft at the newly opened axogen processing center (apc), in dayton, ohio.
AXGN Ratings Summary
AXGN Quant Ranking